ReadyRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.6/10
Best for: compounded semaglutide at one price for every dose, with coaching and meal plans included
ReadyRx falls below our bar on disclosure. It charges from $249 a month; its compounded tirzepatide, at $315, is 17% above the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Prices checked October 2026
ReadyRx sells compounded semaglutide at $249 a month and compounded tirzepatide at $315, the same at every dose, after a first month of $229 and $295. Quarterly plans paid up front drop those to $199 and $275 a month. Plans include coaching, meal plans, free shipping and physician messaging. It also sells brand Ozempic and Zepbound, plus sermorelin, NAD+, glutathione and MIC+B12. It shows a LegitScript seal but names no pharmacy, clinician or states served.
Is ReadyRx legit?
Yes. ReadyRx is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 5.6/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a ReadyRx promo or coupon code?
We know of no promo or coupon code for ReadyRx. Its listed price is $249 a month. Coupon sites advertising "ReadyRx discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how ReadyRx compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to ReadyRx
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
RxSpan MD
Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy
Editorial score · methodology
ReadyRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Brand Ozempic/Zepbound
- Starting price
- $249/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Consult · Shipping · Coaching
- FDA status
- No FDA warning letters found
How ReadyRx scores
Six columns, each one computed from something ReadyRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.9/10$315/month is 17% above the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.5/10The price covers clinician visits, shipping and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on ReadyRx
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for ReadyRx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with ReadyRx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1ReadyRx shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask ReadyRx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes clinician visits, shipping and coaching.
- Lowest ongoing monthly price: semaglutide $249, tirzepatide $315. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that ReadyRx serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Cancelling ReadyRx
Taken from the terms ReadyRx publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None on the monthly plan; the quarterly plan is paid up front
- Refund policy
- Not published by the seller
Medications ReadyRx lists
ReadyRx lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides ReadyRx offers
ReadyRx sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
First month $229. Quarterly plan paid up front: $179 first month, then $199 a month.
First month $295. Quarterly plan paid up front: $255 first month, then $275 a month.
Check the price yourself before you pay
Every figure here comes from ReadyRx's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- The monthly price stays the same as your dose goes up
- The monthly price includes clinician visits, shipping and coaching
- We found no FDA warning letters issued to ReadyRx
Against it
- Semaglutide costs $249 a month, 25% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $315 a month, 17% above the $269 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What ReadyRx charges
The standing price at ReadyRx is $249/month, unchanged as the dose goes up. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide: $249/month
- Compounded tirzepatide: $315/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so ReadyRx's $315 is a premium, and a premium has to buy something. Check what is bundled before you accept it. Before you pay, compare ReadyRx's cancellation terms with other sellers' cancellation and refund policies. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Wellorithm dispenses semaglutide and tirzepatide from $247/month, which makes it the fair comparison to run before you commit here.
What ReadyRx dispenses
ReadyRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
Before you start an intake, ask ReadyRx which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. It does offer coaching as part of the plan. We found no FDA warning letters issued to ReadyRx. The pharmacy question matters most here because the medication is compounded. If ReadyRx will not name the pharmacy, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
ReadyRx also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether ReadyRx bills your plan before you start.
It fits if
- you want the price to stop moving as your dose climbs
- you want coaching bundled in rather than billed on top
Our read
ReadyRx costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. The catch is disclosure, which is why ReadyRx scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Direct Meds is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
ReadyRx falls below our bar on disclosure. It charges from $249 a month; its compounded tirzepatide, at $315, is 17% above the $269 median among the sellers we compare.
Before you pay ReadyRx
Starting at $249 a month. Check today's price, then start the intake.
Where ReadyRx is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
If none of these fits, our guide to alternatives to ReadyRx sets more sellers in the same category beside ReadyRx on price, states and what the price includes.
Frequently Asked Questions
How to check ReadyRx yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this ReadyRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See ReadyRx's current pricing
Plans start at $249 a month. Whether you qualify is a clinician's decision, made after your intake.